Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 8OTHER_GOV 2INDUSTRY 2

Study Type

Observational 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Neoplasms 73Breast Neoplasms 71Colorectal Neoplasms 42Prostatic Neoplasms 35Lung Neoplasms 30Stomach Neoplasms 27Uterine Cervical Neoplasms 25Carcinoma, Non-Small-Cell Lung 22Endometrial Neoplasms 20Ovarian Neoplasms 19Carcinoma, Hepatocellular 19Rectal Neoplasms 18Thyroid Neoplasms 16Colonic Neoplasms 16Urinary Bladder Neoplasms 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Pancreatic Neoplasms 15Esophageal Neoplasms 14Multiple Myeloma 12Gastrointestinal Neoplasms 11Recurrence 10Neoplasm Metastasis 10Sarcopenia 9Obesity 9Leukemia, Myeloid, Acute 9Disease 9Thyroid Cancer, Papillary 8Polycystic Ovary Syndrome 8Melanoma 8Lymphoma 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Observational × Pancreatic Ductal Adenocarcinoma × Clear all
NCT04802993 2021-03-17

Survival Among Patients With Pancreatic Cancer Depending on Surgical Resection Rate

Linkoeping University

Completed
5,123 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT03973736 2019-06-04

RevRadPAC

Azienda USL Reggio Emilia - IRCCS

Completed
316 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡